Ephraim Zagelbaum is the Founder and CEO of Personal Healthcare.
December 21 2018
The Alzheimer’s disease is the most common type of dementia which poses major challenges for patients, loved ones, caregivers, and the nation's healthcare system. According to Ephraim Zagelbaum, the founder and CEO of Personal Healthcare, this disease is the leading cause of death in the U.S. There is no cure for this disease.

Zagelbaum explains that the Alzheimer’s disease comes on gradually. During the earliest stages, people tend to appear normal. However, the symptoms slowly become more obvious, as the disease progresses and tend to affect the everyday life of the people who have it.
As Zagelbaum further explains, the disease affects every patient differently. However, according to Zagelbaum, who is a member of Center for Health Journalism, the most characteristic symptoms of Alzheimer's disease include:
Zagelbaum has authored many research publications on this topic. New discoveries are made about how this disease affects the brain. It has been discovered that this disease causes changes to a person’s brain at both a structural and cellular level.
At structural level, the limbic system is impaired first, followed by the cerebral cortex and then the brain stem. The formation of new blood vessels in different parts of the brain can be also prevented.
At the cellular level, the brain cells, known as neurons are being progressively destroyed. The area of the brain that has been affected from the death of the neurons starts to shrink.
According to Zagelbaum’s publications on Medium, two proteins are thought to play a role in that process:
The Alzheimer’s disease, in Zagelbaum’s opinion, for people that suffer from it it’s like their “lights” are slowly being dimmed and shout off. And, there is no way to turn those lights back on.
Antoher thing that Zagelbam has mentioned is that damage usually begins 10 or more years before any symptom emerge.
Furthermore, Ephraim Zagelbaum has shared on Twitter some additional facts about Alzheimer's disease:
Comment on this post